v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 2,897 $ 3,319 $ 6,628 $ 10,197
Cost of revenue 1,084 1,569 2,919 5,288
Gross profit 1,813 1,750 3,709 4,909
Operating expenses:        
Sales and marketing 1,740 2,818 5,972 8,666
Research and development 599 1,149 1,762 4,032
General and administrative 1,706 1,573 5,836 6,011
Impairment of goodwill 189 0 189 0
Restructuring 0 0 244
Total operating expenses 4,234 5,540 14,003 18,709
Loss from operations (2,421) (3,790) (10,294) (13,800)
Other income (expense), net:        
Interest expense (23) (88) (113) (316)
Gain (loss) on revaluation of warrant liabilities 4,476 4,430 (1,579) 6,045
Loss on modification of warrant 0 0 0 (257)
Warrant issuance expense 0 0 (329) (706)
Other income (expense), net 420 (346) 466 (377)
Total other income (expense), net 4,873 3,996 (1,555) 4,389
Net income (loss) 2,452 206 (11,849) (9,411)
Other comprehensive (loss) income (415) 324 (435) 366
Comprehensive income (loss) $ 2,037 $ 530 $ (12,284) $ (9,045)
Basic net income (loss) per share applicable to common shareholders (in dollars per share) $ 0.30 $ 0.04 $ (1.75) $ (2.01)
Diluted net (loss) income per share applicable to common shareholders (in dollars per share) $ (0.01) $ 0.04 $ (1.78) $ (2.01)
Weighted average number of shares outstanding, basic (in shares) 8,236 4,996 6,772 4,684
Weighted average number of shares outstanding, diluted (in shares) 8,379 4,997 6,829 4,684

Source